baber/WOPTO huggingface dataset:
Patent NZ-578783-A (NZ)
Title: Conveyor machine having pivot connector comprising curved track and rollers engaging track
Inventor: DEMONG MAURICE
IPC: B60D1/24
Filed: 2008-02-07
Abstract: A hitch apparatus for use on a first mobile machine such as a conveyor vehicle to be used with a second mobile machine connected to the first machine. The apparatus includes a track 46 adapted for mounting at an end of the first machine, this track 46 having two opposite sides and bent to form a circular arc having a centre of curvature. A hitch unit is mounted for rolling movement on the track and can pivotably connect the end of the first machine to the second machine. The hitch unit includes rollers 50, 52 for engaging both of the opposite sides so that the track 46 is captured between the rollers 50, 52. The first machine is able to pivot about a substantially vertical axis extending through the centre of curvature of the track 46, relative to the second machine and is connected to the second machine for movement therewith. The apparatus allows frequent movement and adjustment of a conveyer system.
Patent NZ-581667-A (NZ)
Title: Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
Inventor: CHEN SHU-PING
IPC: C07D213/00
Filed: 2008-06-24
Abstract: A process of making crystalline polymorph of 7-ethyl-10-hydroxycamptothecin exhibiting an X-ray diffraction pattern having peaks at 10.9±0.2, 13.2±0.2, 23.9±0.2, and 26.1±0.2 2-theta degree is disclose, wherein the process comprises:(1) dissolving crude 7-ethyl-10-hydroxycamptothecin with a solvent selected from the group consisting of acetic acid, dimethyl sulfoxide, N,N-dimethylacetamide and mixtures thereof to form a solution (wherein the dissolving is preferably carried out at a temperature of at least 80 deg. Celsius); (2) forming crystals of 7-ethyl-10-hydroxycamptothecin by adding an antisolvent selected from the group consisting of 1,2-dichloroethane, acetone, ethyl acetate, ethanol, and mixtures thereof to the solution of step (1) to obtain a slurry (wherein the step (2) is preferably conducted at a temperature of 0-30 deg. Celsius); and(3) filtering the slurry of step (2) to obtain the crystalline solid 7-ethyl-10-hydroxycamptothecin.
Patent NZ-584098-A (NZ)
Title: 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
Inventor: MUELLER RUDOLF
IPC: C07D239/88
Filed: 2008-09-19
Abstract: Disclosed are compounds of formula (I), being fused tricyclic aryl moieties comprising triazine or pyrimidine moieties, salts thereof, and methods for their preparation. Specific examples of compounds of formula (I) include: 3-Cyclopropyl-8-[(2R)-1-(5-methyl-2H-tetrazol-2-yl)propan-2-yl]-3,8-dihydrobenzo[1,2-d:4,5-d']bis[1,2,3]triazine-4,9-dione, 3-But-3-yn-1-yl-8-[(2R)-1-(1H-tetrazol-1-yl)propan-2-yl]-3,8-dihydrobenzo[1,2-d:4,5-d']bis[1,2,3]triazine-4,9-dione, 3-Methyl-8-[1-(1H-pyrazo1-1-yl)propan-2-y1]-3,8-dihydrobenzo[1,2-d:4,5-d']bis[1,2,3]triazine-4,9-dione, 3-But-2-yn-1-yl-8-[(2R)-1-(2H-1,2,3-triazol-2-yl)propan-2-yl]-3,8-dihydrobenzo[1,2-d:4,5-d']bis[1,2,3]triazine-4,9-dione, and 3-(2-Hydroxy-2-methylpropyl)-8-[(2R)-1-(2H-tetrazol-2-yl)propan-2-yl]-3,8-dihydrobenzo[1,2-d:4,5-d']bis[1,2,3]triazine-4,9-dione. Also disclosed is the use of the compound of formula (I) in the treatment of schizophrenia, Parkinson's disease, ADHD, Rett Syndrome, respiratory depression, Fragile-X Syndrome, Alzheimer's disease, Depression, Huntington's Disease, traumatic brain injury, and in the recovery from a stroke.
Patent NZ-587654-A (NZ)
Title: Device for removing fine-grained or dust-like solids from a container by using a tangential injection of gas to produce an eddy
Inventor: KUSKE EBERHARD
IPC: B01J8/00
Filed: 2009-02-27
Abstract: 587654 A Device for removing fine-grained or dust-like solids from a container that is to be pressurized or is pressurized, where the container is equipped with a double-walled discharge cone or funnel, having at least one gas feed into a ring chamber 6 formed by the doublewalled funnel, and an interior funnel wall that faces the funnel interior being provided with gas exit openings 4. The gas exit openings 4 are larger than the largest particles of the solid to be removed, and are provided with a pipe connector or gas feed channel 8 that projects into the interior of the ring chamber 6 and has at least one angle with an imaginary horizontal plane. The gas feed channel 8 is part of a retention device for preventing solid from trickling into the ring chamber 6. Injection of the gas into the ring chamber 6 in the vicinity of a lower floor 9 takes place tangentially with respect to the interior funnel wall to provide an eddy-like flow in the ring chamber 6 that swirls up any solid particles that might be situated there. The arrangement is further characterized in that the ring chamber 6 is equipped with at least one double floor for forming a lower partial ring chamber 6, in the direction of gravity, has at least one gas feed and has one or a plurality of gas exit nozzles on the lower ring chamber floor 9.
Patent NZ-589398-A (NZ)
Title: Fungicidal compositions containing mandipropamid and a benzonobornene amide derivative useful for controlling diseases on plants caused by phytopathogens
Inventor: TOBLER HANS
IPC: A01N43/56
Filed: 2008-04-23
Abstract: Disclosed is a composition suitable for control of diseases caused by phytopathogens comprising (A) a tricyclic amine derivative compound of formula I wherein R1 is difluoromethyl or trifluoromethyl and X is chloro, fluoro or bromo; and (B) mandipropamid. Also disclosed is a method of controlling diseases on useful plants or on propagation material thereof caused by phytopathogens, which comprises applying to the useful plants, the locus thereof or propagation material thereof a composition comprising a compound of formula (I) and mandipropamid. (62) Divided Out of 580186
Patent NZ-591703-A (NZ)
Title: Low acrylamide french fry and preparation process
Inventor: COLLINGE SUSAN F
IPC: A23L19/18
Filed: 2009-09-29
Abstract: 591703 Disclosed is a process for producing finish-fried French fry potato strip with a low acrylamide level of less than about 100 ppb, said process comprising the steps of: selecting raw potatoes having a low natural sugar content; cutting the raw potatoes into elongated strips; blanching the elongated potato strips; applying an aqueous solution comprising at least one food grade coloring agent to coat external surfaces of the blanched potato strips substantially in the absence of added reducing sugar; parfrying the coated potato strips; and finish preparing the parfried potato strips by finish frying in hot oil.
Patent NZ-591831-A (NZ)
Title: Control of selection and modification of calibration operating parameters in a power wheelchair
Inventor: JAENKE BRUCE A
IPC: G05B19/10
Filed: 2006-08-31
Abstract: An apparatus associated with a power driven wheelchair and a method of calibrating one or more operating parameters of a power driven wheelchair are disclosed. The apparatus comprises one or more input devices (64) for selective activation; and system controller (32). The system controller comprises a mounting portion for mounting the system controller to the power driven wheelchair; a display device (66); a first non-volatile storage device (70) storing one or more sets of calibration parameters associated with operation of the power driven wheelchair and a microcontroller. The microcomputer (82) comprises logic that controls display of the interactive screen on the display device; and logic that controls selection and modification of one or more calibration parameters stored on the first non-volatile memory device in response to activation of one or more input devices.
Patent NZ-593250-A (NZ)
Title: An animal crush weighing assembly with load measuring devices located between crush and mounting legs on outer side of crush
Inventor: STARK GARY
IPC: G01G17/08
Filed: 2011-06-03
Abstract: A side mounted animal crush weighing assembly including a crush cage and a plurality of leg assemblies, the crush cage mounted relative to the leg assemblies with at least one load measuring device therebetween and each of the leg assembly is mounted outside the crush cage.
Patent NZ-593941-A (NZ)
Title: Water shoes with underwater fin shaped bellow traction elements streamlined in the forward direction and expanded in the reverse
Inventor: FISHER-MARSTERS KIRSTEN ANDREA
IPC: B63B34/56
Filed: 2011-07-07
Abstract: 593941 Disclosed is a water strider system for recreation and transport on the surface of a water body. The system comprises two pontoons sufficiently buoyant to, when acting together, allows a person to be supported on top of a body of water. Each pontoon comprises an elongate hull that has a bow and a stem and that defines a standing zone, containing a foot well and foot strap binding, for a foot of a person to be supported, and at least one fin shaped traction element disposed from the hull at a location to be submerged in the water. Each traction element is able to re-configure between a streamline configuration corresponding to when the hull is moving forward through the body of water and a less streamline configuration when the hull is moving backwards through the water. In the less streamline condition, by virtue of the traction element having at least two sections configured to bellow towards and away from each other between a position closer together corresponding to the streamline configuration where a volume of water is captured between the two sections and a second position apart corresponding to the less streamline configuration where a larger volume of water is captured between the two sections so that the traction element makes the hull more difficult to move backwards than it does moving forwards though the body of water. Two stability poles with a blade or paddle, each to be grasped by a person in each hand at a handle, the poles are long enough to allow them to reach the water adjacent the person standing on pontoons. Each pole includes a float at or near the end of the pole help provide support to the person when at least partially submerged in the water.
Patent NZ-596623-A (NZ)
Title: Methods and compositions for improving the health of animals
Inventor: DAROSZEWSKI JANUSZ
IPC: A61K31/015
Filed: 2010-04-30
Abstract: 596623 Disclosed herein the use of a oxidatively transformed carotenoid comprising a polymeric component formed by reaction of 6 to 8 molar equivalents of oxygen with a carotenoid such as a beta-carotene derivative, in the manufacture of a composition for improving or maintaining the coat quality of an animal such as a dog, cat or horse. Said composition is optionally formulated for oral administration by mixing with food.
Patent NZ-597653-A (NZ)
Title: Anchoring adhesive combination and integrated method of applying it
Inventor: ROURKE ANDREW J
IPC: F16B13/14
Filed: 2010-07-14
Abstract: An anchoring adhesive combination includes a slug or package of chemical anchoring adhesive having a proximal end and a distal end and a rod which can be a penetrator having a pointed proximal end, and open distal end, and a threaded or corrugated outer surface. The pointed proximal end of the penetrator is connected to the distal end of the slug or package of chemical anchoring adhesive so that the pointed proximal end is at least partially surrounded by chemical anchoring adhesive. The open distal end of the penetrator receives a proximal end of an anchor pin to form a combination of anchor pin, penetrator and slug or package of anchoring adhesive in series. By placing the combination adjacent to a borehole and simply pounding a distal end of the anchor pin an integrated method is performed whereby a) anchoring adhesive is released and mixed in the borehole, b) the inner wall of the borehole is scrubbed and scored by the outer surface of the penetrator, and c) the anchor pin is both mechanically anchored in the borehole using the penetrator and chemically anchored using the mixed chemical anchoring adhesive.
Patent NZ-599196-A (NZ)
Title: Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
Inventor: INOUE HEATHER
IPC: G01N33/53
Filed: 2004-07-15
Abstract: Patent No. 599196 Disclosed is an isolated monoclonal antibody that specifically binds to an epitope on human nerve growth factor (NGF), as an isolated monoclonal antibody comprising a heavy chain variable region, wherein the heavy chain variable region comprises CDR1 (SYSMN), CDR2 (YISRSSHTIFYADSVK), and CDR3 (VYSSGWHVSDYFDY) and a light chain variable region, wherein the light chain variable region comprises CDR1 (RASQGISSALA), CDR2 (DASSLES), and CDR3 (QQFNSYPLT).
Patent NZ-599465-A (NZ)
Title: Methods and installations for manufacturing biaxially oriented tubing and the tubing itself
Inventor: VISSCHER JAN
IPC: B29C48/355
Filed: 2010-10-18
Abstract: 599465 A plastic (PVC) pipe extrusion line for producing bi-axially oriented tube or pipe is provided with improvements, a first of which is to provide a sealing member at the head of the run on part 201 within the lumen of the tube 10 in preform condition before expansion. The sealing member forms a seal with the moving internal surface of the preform 10 so that pressurized gas introduced into the space 210 between the internal surface of the preform and the downstream run on part 201 and the expansion part 200a, 200b does not leak into the lumen of the preform upstream of the seal. One or more gas discharge ducts 250 are formed in the expansion device, said one or more gas discharge ducts having one or more inlet ports 250a in the exterior surface of the expansion part of the expansion device, an inlet port being open or closed dependent on whether or not the inlet port is covered and closed by the tube 10, the gas discharge duct allowing – in use of the installation - for the relief of gas pressure from the fluid volume 210 when the one or more corresponding inlet ports are open thereby reducing the expansion of the tube caused by internal gas pressure, the relief of gas pressure continuing until the one or more corresponding inlet ports are covered and closed again by the tube.
Patent NZ-600126-A (NZ)
Title: Purine derivatives for use in the treatment of fap-related diseases
Inventor: HIMMELSBACH FRANK
IPC: A61K31/5025
Filed: 2008-08-15
Abstract: ABSTRACT - 600126 The disclosure relates to the use of selected purine derivatives represented by formula (I) or (II), tautomer, enantiomer or salt thereof, or a mixture thereof, for preparing a pharmaceutical composition for the treatment of a hyperproliferative disease that responds to the inhibition of Fibroblast Activation Protein (FAP), wherein the disease is selected from cardiac hypertrophy, cirrhosis and fibromatoses, or from wound healing disorders, acne and a proliferative skin disease such as psoriasis. Examples of these purine derivatives include: 1-[(quinazolin-2-yl)methyl]-3-methyl-7-(2- butyn-1-yl)-8-((R)-3-amino-piperidin-1-yl)-xanthine; 2-((R)-3-amino-piperidin-1-yl)-3-(but-2-ynyl)-5-(4-methyl-quinazolin-2-ylmethyl)-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one, and the like.
Patent NZ-601564-A (NZ)
Title: Method and system of a timer based buffer used for metrology
Inventor: REE BRADLEY RICHARD
IPC: G01D4/00
Filed: 2012-07-31
Abstract: Disclosed is a meter for use in utility distribution system. The meter is comprised of one or more metrology sensors (402), a dynamic random access memory (DRAM) (412), a non-volatile random access memory (NVRAM) (414), a timer, a network interface (408) and a processor (404). The processor (404) is operably connected with the one or more metrology sensors (402), the DRAM (412), the NVRAM (414), the network interface (408) and the timer. The processor (404) is configured to receive metrology data from the one or more metrology sensors (402) and write at least part of the metrology data to the DRAM (412). The processor (404) is configured to then increment a write pointer indicating the location of the metrology data contained within the DRAM (412) and monitor the timer for the expiration of a pre-determined time period. Until the expiration of the pre-determined time period, the processor (404) receives and writes metrology data and upon expiration of the pre-determined time period, the processor (404) is configured to set the write pointer as a read pointer. The processor (404) is configured to then read at least a portion of the metrology data from the DRAM (412) up to an amount of metrology data as indicated by the read pointer. The processor (404) is also configured to write at least the portion of the metrology data read from the DRAM (412) to the NVRAM (414).
Patent NZ-605473-A (NZ)
Title: Synergistic herbicidal compositions containing aminopyralid, 2,4-dichlorophenoxyacetic acid and atrazine
Inventor: RODRIGUEZ CONTRERAS SERGIO
IPC: A01N39/04
Filed: 2011-07-13
Abstract: Disclosed is a synergistic herbicidal mixture comprising an herbicidally effective amount of (a) aminopyralid (4-amino-3,6-dichloro-2-pyridinecarboxylic acid) and 2,4-D (2,4-dichlorophenoxyacetic acid) and (b) atrazine (1-chloro-3-ethylamino-5-isopropylamino-2,4,6-triazine), preferably a mixture in which the weight ratio of aminopyralid to 2,4-D is between 1:15 and 1:25 on an acid equivalent basis and the weight ratio of aminopyralid (acid equivalent) to atrazine is between 1:25 and 1:100. Also disclosed is a method of controlling undesirable vegetation (such as redroot pigweed or bur-cucumber) which comprises contacting the vegetation or the locus thereof with a herbicidally effective amount of the herbicidal mixture as defined above.
Patent NZ-609908-A (NZ)
Title: Models of thrombotic thrombocytopenic purpura and methods of use thereof
Inventor: SCHWARZ HANS-PETER
IPC: C12N15/85
Filed: 2009-10-27
Abstract: Disclosed is a mouse model of Thrombotic Thrombocytopenic Purpura (TTP) comprising a transgenic mouse, wherein the transgenic mouse expresses recombinant human von Willebrand factor (rVWF) from a transgene comprising a polynucleotide encoding rVWF, wherein the rVWF composition forms high molecular weight multimers, and wherein the expression results in a symptom of TTP selected from the group consisting of: reduced platelet levels, anemia, histopathological effects, increased blood creatinine kinase levels, increased lactate dehydrogenase levels, and increased microthrombi., Also disclosed is a method of inducing symptoms of Thrombotic Thrombocytopenic Purpura (TTP) in a mouse, said method comprising the step of administering to the mouse a composition comprising recombinant human von Willebrand factor (rVWF) in an amount effective to result in a symptom of TTP, wherein the rVWF composition forms high molecular weight multimers, and wherein the symptom of TTP in the mouse is selected from the group consisting of: reduced platelet levels, anemia, histopathological effects, increased blood creatinine kinase levels, increased lactate dehydrogenase levels, and increased microthrombi.
Patent NZ-613028-A (NZ)
Title: Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
Inventor: KALLEL EDWARD ADAM
IPC: C07D471/20
Filed: 2012-02-02
Abstract: Disclosed are pyrrolopyrazine-spirocyclic piperidine amide compounds of formula (I) useful as inhibitors of ion channels. Also disclosed are pharmaceutically acceptable compositions comprising the compounds of formula (I) and methods of using the compositions in the treatment of various disorders. Examples of compounds of formula (I) are: 1-(1-(4-Isopropoxy-3-methoxybenzoyl)-6’-(trifluoromethyl)-3’,4’-dihydro-2’H-spiro[piperidine-4,1’-pyrrolo[1,2-a]pyrazine]-2’-yl)ethanone; 2,2,2-Trifluoro-1-[1’-[4-(2-methoxy-3-pyridyl)-3-methyl-benzoyl]-2-methyl-spiro[3,4-dihydropyrrolo [1,2-a] pyrazine-1,4’-piperidine]-6-yl] ethanone and (2-(3-Hydroxypyrrolidin-1-yl)pyridin-3-yl)(2’-methyl-6’-(trifluoromethyl)-3’,4’-dihydro-2’H-spiro[piperidine-4,1’-pyrrolo[1,2-a]pyrazine]-1-yl)methanone.
Patent NZ-613996-A (NZ)
Title: System and method for forest management using stand development performance as measured by leaf area index
Inventor: ROJAS JULIO C
IPC: G06F15/00
Filed: 2012-03-22
Abstract: A system and method for identifying stands (10) or portions thereof that are not growing as expected. In one embodiment, a computer system (100) compares a measured leaf area index of a stand (10) that is determined from remotely sensed data to an expected leaf area index. The computer system (100) identifies stands (10) or portions of stands where the measured leaf area index is greater than the expected leaf area index (150) and/or stands (10) or portions of stands where the measured leaf area index is less than the expected leaf area index (150). In one embodiment, the comparison is used to identify stands (10) or portions thereof where silviculture treatments may be necessary. In another embodiment, measured vegetation index or leaf area index values are used to manage the growth of secondary crops in a stand. VI or leaf area index values are compared with expected values (150) to determine if silviculture treatments should be applied.
Patent NZ-700902-A (NZ)
Title: Lowering saturated fatty acid content of plant seeds
Inventor: BEVAN SCOTT
IPC: C12P7/64
Filed: 2011-06-24
Abstract: Disclosed is an isolated nucleic acid molecule, and methods of use thereof, encoding a delta-9 desaturase enzyme comprising an amino acid sequence that is at least 80% identical to SEQ ID NO: 13, wherein the nucleic acid molecule comprises a nucleotide sequence at least 60% identical to a sequence selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 16, and SEQ ID NO: 45; further comprising a gene regulatory element; wherein the sequences are as defined in the specification.
Patent NZ-703547-A (NZ)
Title: Composition comprising superabsorbent polymer
Inventor: GRUSSING JEFFREY F
IPC: C08L33/02
Filed: 2013-06-10
Abstract: Disclosed is a composition (e.g., a texture composition) comprising, consisting of, or consisting essentially of calcium carbonate and superabsorbent polymer that can absorb at least about 50 times its mass and having a particle size of about 250 microns or less, wherein the superabsorbent polymer is prepared from the polymerization of acrylic acid blended with sodium hydroxide in the presence of an initiator to form a poly-acrylic acid sodium salt or wherein the superabsorbent polymer is made from polyacrylamide copolymer, ethylene maleic anhydride copolymer, cross-linked carboxy-methylcellulose, polyvinyl alcohol copolymers, cross-linked polyethylene oxide, starch grafted copolymer of polyacrylonitrile, or starch grafted polyacrylamide, wherein the composition is substantially free of a setting-type cementitious material, wherein the composition hardens upon drying, and wherein the composition has a viscosity of from about 150 to about 800 Brabender units. Also disclosed is a method of finishing a substrate comprising applying to the surface the aforesaid composition comprising, consisting of, or consisting essentially of calcium carbonate and superabsorbent polymer that can absorb at least about 50 times its mass and having a particle size of about 250 microns or less, wherein the superabsorbent polymer is prepared from the polymerization of acrylic acid blended with sodium hydroxide in the presence of an initiator to form a poly-acrylic acid sodium salt or wherein the superabsorbent polymer is made from polyacrylamide copolymer, ethylene maleic anhydride copolymer, cross-linked carboxy-methylcellulose, polyvinyl alcohol copolymers, cross-linked polyethylene oxide, starch grafted copolymer of polyacrylonitrile, or starch grafted polyacrylamide, wherein the composition is substantially free of a setting-type cementitious material, wherein the composition hardens upon drying, and wherein the composition has a viscosity of from about 150 to about 800 Brabender units.